Advanced patient-derived primary culture and 3D biomimetic scaffold simulator.
AI-optimized bioinks are bioprinted into precise three-dimensional tissue architectures.
Cells mature into functional living tissue under controlled culture.
Multiple human cell types interact within the matured tissue to recreate the native disease microenvironment.
The in-vitro disease model is used to evaluate drug efficacy, toxicity, dose response, and therapeutic outcomes, generating predictive human-relevant data before clinical studies.